Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
21,191
Total Claims
$1.6M
Drug Cost
1,055
Beneficiaries
$1,489
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-98%
Opioid rate vs peers
0.1% vs 2.6% avg
+39%
Cost per patient vs peers
$1,489 vs $1,068 avg
+33%
Brand preference vs peers
12.0% vs 9.0% avg
Opioid Prescribing
0.1%
Opioid Rate
12
Opioid Claims
$60
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,496 claims · $1.3M
Generic: 18,317 claims · $281K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 199 | $196K |
| Dapagliflozin Propanediol | 240 | $168K |
| Rivaroxaban | 175 | $113K |
| Apixaban | 141 | $101K |
| Empagliflozin | 94 | $77K |
| Insulin Glargine,hum.Rec.Anlog | 122 | $57K |
| Sitagliptin Phosphate | 68 | $54K |
| Mirabegron | 67 | $36K |
| Insulin Aspart | 56 | $36K |
| Sacubitril/Valsartan | 31 | $33K |
| Linaclotide | 48 | $28K |
| Semaglutide | 25 | $27K |
| Dulaglutide | 22 | $22K |
| Atorvastatin Calcium | 1,470 | $20K |
| Denosumab | 11 | $19K |
Prescribing Profile
Patient Profile
75
Avg Age
59%
Female
1.87
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data